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ABSTRACT 
The purpose of this series of studies was to investigate the 
interaction of d-amphetamine and amantadine hydrochloride employing 
serial discrimination reversals with repeated acquisitions. Specifi� 
cally, the blockade of the effects of d-amphetamine by amantadine 
hydrochloride was investiga ted. 
In meeting this goal, dose-response curves were determined 
independently for d-amphetamine and amantadine hydrochloride. The dose­
response curve for d-amphetamine indicated that the 0 . 5  mg/kg dosage 
provided for optimal discrimina tion of SDR, while dosages of . 1 . 0 mg/kg 
and 2 . 0  mg/kg proved to be disruptive. The experiments investigating 
amantadine hydrochloride indicated that dosages above 1 0  mg/kg were 
detrimental to the discrimination task, while dosages below 1 0  mg/kg 
seemed to have negligible effect. 
The analysis of the final experiment, in which amantadine 
�ydrochloride was given as a pretrea tment 90 minutes before d-ampheta­
mine treatment, indicated that amantadine hydrochloride did not block 
the effects of d-amphetamine on learning. Rather, the interaction of 
the two drugs a ppears to be synergistic in nature rather than inhibitory. 
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CHAPTER I 
INTRODUCTION 
Measuring Drug Effects ·on Learning 
Research on drug effects can be loosely classified in two 
categories: (1) the study of drug· effects on behavio.r (performance ) 
and (2) the study of drug effects on learning. Generally� the first 
type of research is well-developed and suitable research methods exist. 
For example, operant schedules of reinforcement have been used in 
investigating the effects of drugs on behavior. 
Operant schedules of reinforcement provide for good behavioral 
control as well as permitting cross-situational analysis  of a given 
drug dosage under the various schedules. When utilized.in  this manner, 
the effect of a given drug dosage on such performance vari ables as· 
response rate can be determined under several conditions. In addition, 
operant schedules provide for a repeated testing situation, or one in 
which each subject can serve as his own control ( Boren, 1966 ; Kelleher 
·and Morse, 1968; Thempson and Schuster, 1968). 
In contrast to the methods used in studying,the effects of 
drugs on performance, the methods used in studying effects of drugs 
on learning are not well�developed and are often insensitive. In­
cluded among the methods which have been used for this purpose are 
two-way shuttle box avoidance, one-trial passive avoidance, and maze 
learning. 
1 
Research with scopolamine (Oliverio, 1967) indicated that the 
drug facilitated learning in the two-way avoidance situation. However, 
later research using passive avoidance {Calhoun, 197 1) indicated that 
scopolamine interfered with learning. It appeared that the drug was 
producing contradictory effects in two "learning" situations. In fact, 
the drug was causing an increase in activity which was facilitatory 
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in the first situation and detrimental in the second. Thus, the measures 
used were not suitable as models for the learning process. 
Similar problems are encountered with maze learning. For 
example, if running time were the main dependent measure in a given 
maze task, a drug which increased activity might result in faster maze 
completion, and to the false conclusion that learning was facilitated. 
In addition, in each of these cases it is impossible to reverse the 
conditions or to test the drug effect more than once on a problem. 
Therefore, it is impossible to note any permanent or long term changes 
which might result from drug usage�. 
From problems such as these, it is clear that there is a need 
for the development of an experimental methodology which would pro­
vide a sensitive measure of learning, and not solely performance. It 
is suggested here that the use of a repeated acquisition method similar 
to that employed by Boren and Dev ine (1968) may solve some of the 
problems previously encountered. 
Repeated Acquisitions as a Method for Studying 
Drug Effects on Learning 
With the repeated acquisition procedure, an animal learns a series 
of similar problems until acquisition on successive problems becomes 
stable. Rhesus monkeys, serving as subjects in the Boren and Devine 
(1968) study, were required to learn a new four-response chain within 
each session . "A stable pattern of learning resulted, and the number 
of errors reached a steady state from session to session" (Boren and 
Devine, 1968). This steady state could then be utilized as a baseline, 
as suggested by Sidman (1960). 
A steady state, as defined by Sidman, refers to a behavior which 
does not change considerably over time, but which remains stable. 
Therefore, any changes which take place in the steady state behavior 
can be attributed to the experimental manipulations . For studying 
drug effects, a baseline condition has several advantages. It is 
superior to other comparison measures in that it is reversible. That 
is, once the experimental condition is introduced, the behavior can 
return to its original state. This allows for repeated manipulations 
of variables in each subject, as well as for each subject serving as 
his own control. 
On the premise that the Boren and Devine study provided a 
steady state of repeated acquisition, Thompson (1973; 1975) modified 
the design for use with pi geons. In the Thompson study, each subject 
was required to learn a new four-response chai n daily. The task of the 
pigeon was to peck the correct key in the presence of one of four 
colors. There were three keys present in the apparatus, each capable 
of being illuminated by any of four colors. On any one trial, all 
three keys were lighted with the same color cue. Each color was corre­
lated with one ·key position (left, right, or center) on a day-to-day 
basis. That is, on day one the sequence might be as follows: 
3 
yellow lights = peck key on right !R) 
red lights = peck key in center C ) 
green lights = peck key on left L ) 
white lights = peck key in center C ) 
The task of the pigeon was to peck the correct key for each group of 
colors. The same pecking sequence (R-C�L-C) was continued throughout 
the daily session. During the next session the sequence would be 
changed. 
After extended training, each subject reached a stable baseline 
in terms of errors per session. This steady state of repeated acquisi­
tion was then used as the baseline for studying the effects of drugs 
on learning. 
Used in this manner, with each subject serving as its own 
control and providing a stable daily index of learning , the r�peated 
acquisition method appears superior to others. It controls for indi­
vidual differences in learning and, due to the reversible nature of the 
method, can be used for repeated experimental manipulations over an 
extended period of time. 
Learning Set as a Repeated-Acquisition Method 
A well documented example of repeated acquisitions is seen 
with the two object discrimination learning set procedure used by 
Harlow (1949). He found that the early performance of monkeys in a 
learning set situation is different from performance later in training. 
The Wisconsin General Test Apparatus (WGTA) was used for training 
monkeys in a series of two-object discriminations. The task of the 
monkeys was to choose the object which covered the filled foodwell. 
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Choice of the correct sti mulus was rewarded, whi le choice of the other 
sti mulus produced no reward. The posi tion of the correct sti mulus was 
sh i fted from tri al to trial in  a balanced order. It was found that 
early in  trai ni ng the monkeys responded in  a tri al-and-error manner; 
however, after exposure to many si milar problems the probability that 
a monkey will make the correct choice on Trial 2 of a problem 
approaches 100%. It is Harlow's opinion that this change in  behavi or 
represents the development of a learning set. 
Serial Di scrimi nation Reversal Learning 
as a Learning Set Procedure 
Just as learning set is  a special case of the repeated acquisi­
tion method, so is the serial discrimination reversal learning (SDRL ) 
method a speci al case of the learning set procedure. Li ke the learn­
ing set method, SDRL presents a complex problem to the organism and 
provides a method which is  capable of di fferentiating among species 
accordi ng to the phylogenetic level. 
The characteristics of SDRL showing its relation to learning 
set procedures is  the change i n  behav ior with experi ence. On early 
discrimi nati ons the ani mals behave in a trial-and-error fash ion, but 
after a series of reversals learning is qui te rapid and wi th easy 
di scri mi nations ani mals can learn to reverse with only one error 
(Dufort, Guttman, and Ki mble, 1954). A second characteristic of 
SDRL showi ng its relation to learning set procedures is  that SDRL ranks 
closely related speci es in  the same general order that learning set 
5 
does ( Gossette, Gossette, and Riddell, 1966) and SDRL has been suggested 
as a valid procedure for the study of comparative learning ability 
(Gossette, 1966, 1970; Mackintosh, 1969, Sheldon, 1965). 
In SDRL animals are trained to discriminate between two stimuli. 
When the first discrimination has been learned, the reward contingency 
is reversed. Training then continues through a number of such rever­
sals. The usual measure of performance is errors per reversal and 
errors decrease with successive reversals. The error rate eventually 
reaches a stable baseline of performance which can then be used in the 
evaluation of various treatments. 
Both simultaneous (two stimuli and two responses) and successive 
discrimination (one stimulus, one response) training have been used 
in SDRL. Most studies using rats as subjects have employed the simul� 
taneous method, and in most cases progressive improvement has been 
observed in the course of the experiment (Gonzales, Berger, and 
Bitterman, 1966; Stretch, McGonigle, and Rodger·, 1963; Dufort, 
Guttman, and Kimble, 1954; Mackintosh, McGonigle, Holgate, and 
Vanderver, 1968). Although the majority of studies have employed 
simultaneous SDRL there have been several of the successive type. 
North (1962) tested rats in a straight alley maze and d�d not find 
improvement over reversals. Clark (1967) was not able to find improve­
ment in pigeons, but further work by Beale (1970) and Woodard, Scheel 
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and Bitterman (1971) has established that pigeons can acquire the serial 
reversal strategy using successive discriminations. Beale's procedure 
involved a multiple variable interval schedule during s+ and extinc­
tion during s-. The Woodard et al. procedure involved a fixed ratio 
schedule during s+ and extinction during s-. 
The best evidence of improvement in rats trained under the suc­
cessive discrimination reversal method was reported by Khavari and 
Heise (1 967) . They employed a discrete trial operant procedure in 
which the s+ and s- were presented successively. Kulig and Calhoun 
(1 972) further refined the method of Khavari and Heise. Instead of 
using compound stimuli like that ·employed by Khavari and Heise 
(blinking light plus tone or constant light plus tone) , Kulig and 
Calhoun further differentiated the two stimuli by using only a light 
or only a tone as the s+ or s-. 
The methodology developed by Khavari and Heise was tested for 
its effectiveness in drug studies by Kulig and Calhoun in its modified 
form. Methamphetamine was administered to rats trained on successive 
discrimination reversals. A change in the steady state of acquisi­
tion resulted from the administration of the drug (that is, error rate 
decreased) , · suggesting that the successive discrimination reversal 
procedure was sensitive to the treatment. 
J ustification of Successive Discrimination Reversals 
as a Repeated Acquisition Method 
Repeated acquisition methods involve repeatedly testing animals 
on similar problems in order to develop a baseline for acquisition. 
As previously mentioned, learning set methods have been studied with 
a variety of species. Variations of the method exist such as Harlow 
(1 949) , Boren and Devine {1 968) , Beale {1 970) , Woodard et al. (1 971 ) ,  
and Thampson {1973) . Included in the above, and the one most likely 
to serve well in drug screening is the method developed by Khavari and 
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Heise (1 967) . Used in this way, successive discrimination reversal 
learning has the advantage, like the repeated acquisition procedure of 
establishing a stable baseline for each animal against which experi­
mental treatments can be evaluated. 
The successive discrimination reversal method (SDR) tests an 
animal first on one discrimination, and then on successive reversals 
of that discrimination. For example, with a tone versus light discrim­
ination, the first s+ ( the correct and rewarded response ) might be 
tone, with light the s- ( the incorrect and unrewarded response) . 
During the next discrimination, the s+ and s- would be reversed, and 
so on through a series of discrimination reversals. After several 
sessions of successive discrimination reversals, a steady state of 
repeated acquisition develops. Intrasession performance represents 
the acquisition of any one discrimination, while intersession perfor­
mance represents the repeated acquisition baseline. 
Justification of SDR as a valid repeated acquisition method 
rests upon two empirical facts: (1 ) animals trained on a series of 
discrimination reversals develop a steady state of responding; and 
(2) wi thi n  any one di scri mi nati on revers al errors decline di rectly as 
a function of tri als. The data shown in Figure 1 were obtained 
from a single rat for three sessions of baseline SDR. The rat was 
trained on successive discrimination reversals until his performance 
was stable and uniform from session to session. Each session consisted 
of 200 trials, of which 1 00 were correct (S+) and 1 00 incorrect (S-). 
If the animal responded during a correct trial, it was rewarded. If 
the animal responded during an incorrect trial, the response was 
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Figure 1. Cumulative error curves per 10-trial blocks for one rat over 
three successive sessions. 
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counted as an error and was not rei nforced . The data i n  F igure 1 are 
pl otted as cumul atdve errors as  a funct i on of tr i a l bl oc ks, w ith 10 
tri a l s per trial bl oc k .  It shoul d be noted that for the three sess i ons , 
the an imal showed rel at ively uniform day-to-day acqui s it i on . Most 
errors occurred i n  the earl y part of the ses s i on and errors decreased 
as tra i n i ng proceeded . For the animal represented i n  Figure 1 ,  there 
was a marked i ncrease i n  error frequency toward the end of the sess i on .  
Th i s  was poss i bly  due to sat i at i on 0r fatigue .  Figure 2 shows s i mi l ar 
data far another rat . Thi s  .an imal demonstrates very uniform day -to-day 
acqu i s iti on, and the "l earn i ng curves" approxi mate the theoret i cal 
curves . Even though  the an imal had been repeatedly exposed to the 
l ight versus tone d i scrimi nati on ,  he started each ses s i on by ma ki ng a 
fa i rly l arge number of errors. As the ses s i on progressed , the number of 
errors decreased unt i l  d i scri mi nati on performance was nearl y perfect . 
Ev i dence from these f igures demonstrates the reproduc i b i l ity of the 
l earn i ng curve for a s i ngl e an imal . Thus, SDR can be used to devel op 
a repeated acqu i s it i on basel i ne for study i ng drug effects. 
I n  concl us i on, it i s  suggested that the basel i ne SDR procedure 
hol ds promise as a method for analyzing the effects of drugs on 
acqui s it i on .  The advantage of this procedure is the establ i s hment of 
the repeated acquisition basel i ne. The fact that the errors occur 
mo re frequently i n  the earl i er part of the ses s i on and decrease as  a 
funct i on of tri a l s  val i dates the not i on that the an imal i s  actual l y  
l earn i ng the di scr imi nat i on withi n each da i l y  ses s i on . 
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over four successive sessions. 
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Statement o f  Purpose 
As a group, the amphetami nes have been w i dely i nvestigated duri ng 
the l ast decade . Th i s  i nterest has stemmed from a vari ety of reports, 
i nc ludi ng those wh i ch cl a imed that thi s  group of chemi cal  agents 
i ncreased l earn i ng abi l i ty .  More recently ,  amantadi ne hydrochl ori de ,  
an anti -v i ral  agent hav i ng some stimul ant properti es. was reported 
to have b l ocked some of the centra l  nervous system st imu l atory effects 
of dextre-amphetami ne . 
The purposes to be served i n  th i s  seri es of studi es were 
threefol d .  The fi rst  purpose  was to determi ne dose l evel s of d-ampheta­
mi ne wh i ch i ndi cate an enhancement of l earn i ng i n  the repeated acqu i s i ­
ti on s i tuati on . Secondly, dose l evel s of amantadi ne hydrochl ori de 
hav i ng negl ig i bl e effects upon respondi ng were to be determi ned . The 
l ast purpose was to evaluate the effects on acqu i s i ti on when 
d-amphetami ne and amantadi ne hydrochl ori de were g iven i n  conjuncti on 
w i th one another . The a im  i n  choos i ng dose l evel s of amantadi ne hydro­
chl ori de whi ch showed l i ttl e or no mea surabl e effect on acqu i s i ti on 
was an attempt to el imi nate the poss i b i l i ty that any effect noted i n  
the combinati on drug treatment coul d be due to the amantadi ne hydro­
chl ori de al one . 
CHAPTER II 
THE EFFECTS OF d-AMPHETAMINE ON REPEATED ACQUISITIONS 
WITH SERIAL DISCRIMINATION REVERSALS 
The increased popularity of the amphetamines during the past 
decade, along with reports that the drug caused increased alertness 
in the user, have led to large scale research utilizing this class 
of chemicals. There have also been reports of beneficial effects of 
amphetamine on various learning tasks. For various reasons, a great 
deal of the research on the effects of amphetamine on learning has used 
animal subjects. A review of this literature follows. 
As early as 1939, the effects of amphetamine on learning were 
being investigated using maze learning as the task. In that year, 
Minkowsky tested the effects of 0.5 mg/kg dl-amphetamine on the per­
formance of rats. The drug was administered subcutaneously 15 minutes 
prior to the start of the session. The results after drug adminis­
tration showed an increase in errors on the maze performance. This 
led to the conclusion that amphetamine administration resulted in 
impairment of learning. Other maze studies involving the use of 
amphetamine followed. In 1952, Ewing, Moore, and Moore tested rats 
in a multiple T-maze using 1 mg/kg d-amphetamine, 8 mg/kg 1-amphetamine, 
and saline. Early in training, a decrease in errors was observed 
and attributed to the amphetamine administration. However, by the 
seventh day of training, the error rate between groups was not signi­
ficantly different. Overton ( 1964) reported that animals can be 
13 
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trained to turn right in a simple T-maze whether or not they are 
drugged. Furthermore , the animals exhibit no better than chance per­
fonmance while in the state in which the animal was not trained. The 
conclusion reached was that the drug state can serve as a discriminative 
stimulus in various situations. 
From the maze learning paradigm interest shifted to discrimina­
tion learning. Jones (1966), Cole (1970), and Bauer and Duncan (1971) 
reported facilitated discrimination acquisition , performance, and 
reversal as a result of amphetamine treatment. Jones (1966) injected 
one of four doses of d-amphetamine (0.5, 1.0, 2. 0, or 3. 5 mg/kg) or 
saline intraperitoneally one hour before testing in a discrimination 
acquisition experiment. The first three sessions involved operant 
level observations of the rats in a two-lever operant chamber. For 
the next 10 days , the animals were reinforced whenever they pressed 
the lever least pressed during the three day observation period. 
The contingencies were reversed for the final five days of the experi­
ment. At the 0. 5, 1 . 0, and 2. 0 mg/kg levels of d-amphetamine, the total 
number of correct responses increased. These dosages also facilitated 
the reversal. Cole (1970) found food motivated behavior to be similarly 
affected. He used a multiple continuous reinforcement, extinction 
schedule in which rats were reinforced for each lever press in the pres­
ence of light and were never reinforced in the absence of light. 
Under the influence of 0. 5 or 1. 0 mg/kg d-amphetamine , the percentage of 
responses during continuous reinforcement increased. The discrimina­
tion was retarded by 2.0 mg/kg d-amphetamine. All three doses increased 
response rate as a function of increasing dosage. Bauer and Duncan 
15 
(1971) investigated the possibility that d-amphetamine would facilitate 
acquisition when training was started 24 hours after the last injection 
of d-amphetamine. Six groups of rats were tested in an avoidance 
situtation (shuttle-box) . The subjects received an intraperitoneal 
injection of either saline or 2.0 mg/kg d-amphetamine for 2, 5, or 10 
days. Twenty-four hours after the last injection, the animals were 
placed in a shuttle-box. In their second experiment, 44 rats were 
tested in a Y-maze on a light/dark discrimination after receiving 
injections of 2.0 mg/kg d-amphetamine for either 5 or 10 days. Twenty­
four hours later, they had one session of 400 trials in the maze. It 
was found that the multiple injections of d-amphetamine facilitated 
performance on both the positively and negatively reinforced tasks. 
Several investigations concerned with more complex animal learning 
have followed. In these experiments, the organism performs most effi­
ciently when it acquires the use of some rule such as "win stay/lose 
shift.11 Khavari (1969) administered d-amphetamine to animals which 
were trained according to the rule: if the previous trial was rein­
forced, respond; if the previous trial was not reinfoced, don't 
respond. On this task, d-amphetamine disrupted the performance. 
The number of responses on trials following an s- response increased 
and the number of responses on trials one removed from an s-
response decreased. The organism appeared to be more affected by the 
immediate consequences of its action rather than the rule. Kulig and 
Calhoun (1972) reported that methamphetamine enhanced successive dis­
crimination reversal learning. Animals were trained on a light/tone 
discrimination to a criterion. Upon reaching criterion, the 
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conti ngenc i es were reversed , and trai n i ng on the reversed di scrimi na­
ti on conti nued unti l cri teri on was reached. Thi s  procedure conti nued 
for ei ght reversa l s .  Methamphetami ne was admi ni stered 15  mi nutes pri or 
to the ses s i on on Reversal 2 .  Doses of both 2 . 0  and 0 . 5  mg/ kg reduced 
errors on thi s and later revers�l s .  The two drugged groups ma i n-
ta i ned l ower error rates than the control group ani ma l s throughout 
the remai nder of the experi ment . F i na l ly , Cal houn and Jones (1974 )  
reported that methamphetami ne accel erated acqu i si ti on .  Rats were 
tra i ned through a seri es of l i ght vers us tone di scri mi nati ons unti l they 
devel oped a stabl e repeated acqui s i ti on basel i ne .  The animal s were then 
i njected wi th 0 . 25, 0 . 50, or l . O mg/kg methamphetami ne . I t  was found 
that w i th l ow doses , 0 . 25 and 0 . 50 mg/ kg , methamphetami ne reduced 
errors wi thout affecti ng rewarded respondi ng . However , there was 
ev i dence of the drug di srupti ng the operant behav i or at the 1.0 mg/ kg 
l evel . 
The majori ty of the data summari zed here i ndi cate that ampheta­
mi nes enhance l earni ng .  However , i t  was fel t that before try i ng to 
ascertai n the i nteract ion effect of any drug combi nati on , i t  was f i rst 
necessary to establi sh the effects of several dose levels of each 
drug i ndependently .  Because i t  i s  the blockade of the effect of 
d-amphetami ne that i s  under i nvesti gati on i n  thi s seri es of stud ies , 
i t  was des i rabl e to determi ne a dose l evel whi ch produced a measurable 
effect . The f i rst experi ment was conducted to determi ne the appro­
pri ate l evel s of d-amphetami ne .  
General Method 
Subjects · 
The subjects were six experimentally naive, male Wistar rats 
(250-350 g) obtained from the Holtzman Co., Madison, Wisconsin. 
The animals were housed three per cage and were maintained on a 23 
hour water deprivation schedule during the experimental testing. Food 
was available ad libitum throughout the course of the experiment. 
Apparatus 
Six identical one-lever operant chambers (Lafayette Instru­
ments) measuring 28 x 21 x 21  em were used. The lever, requiring 
25 g for micro-switch closure, was mounted 7 em above the floor of the 
chamber in the center of one wall. A 0 . 1 0  ml drop of a 9% sucrose 
solution was presented as reinforcement in a spout mounted 6 em to the 
left of the lever. Stimuli consisted of a 7 W white cue light located 
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6 em directly above the lever, and a 1 000 Hz tone presented by a 
Sonalert located 10 em behind the response lever. A 7 W red house­
light provided constant illumination. Each operant chamber was enclosed 
in a sound attenuating chamber; these were contained in t�ree 1 . 3 x 
3 . 2  x 2 . 2  m experimental cubicles. Fans provided ventilation and 
masking noise. Stimuli were programmed with electromechanical circuitry 
located outside the experimental cubicles. Data was collected on 
counters. 
Procedure 
The subjects were first adapted to a 23 hour water deprivation 
schedule. For three days prior to training, the subjects were allowed 
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access to water for only one hour each day. Following this adaptation, 
the subjects were shaped to bar press for 0.1 cc reinforcement under 
a continuous reinforcement schedule. Neither the light nor the tone 
was presented during this phase of training. The subjects were trained 
under this schedule for one-half hour a day for three days. Following 
acquisition of the bar pressing response, the discrete trial procedure 
was· begun. Daily sessions for each subject consisted of 200 trials. 
Either the tone or the light signalled a six-second trial, separated 
from the following trial by a 10-second intertrial interval (ITI). 
A 20 unit Gellerman series ordered presentation of the trial stimuli. 
A lever press during an s+ (correct) trial terminated the trial and 
produced reinforcement. Lever presses during s- (incorrect) trials 
had no effect; the trial stimulus continued for the programmed six 
seconds. The first lever press during an s- trial was called an error. 
Any response during the 10 second ITI reset the interval timer, thus 
prolonging the ITI. Subjects were allowed free access to water for 
one hour following each daily session. 
SDR training continued until performance stabilized, at which 
time administration of d-amphetamine began. All injections were 
intraperitoneal and were given 15 minutes prior to the session. Each 
animal received .001 cc of solution per gram of body weight of four 
doses of the drug (0.5, 0.75, 1.0, and 2.0 mg/cc) and one control 
injection of physiological saline. Of the many possible permutations 
of the five dosages, 24 were determined. From these 24 drug sequences, 
six were selected. One of these was assigned to each subject. In 
this way the order of drugging was randomized. A restabilization period 
followed each treatment. 
Experiment I. Each of the six subjects was run on SDR until 
stabilized. There were two requirements of a stable baseline. First, 
the animal was required to maintain five day error range equal to or 
less than 10. In addition, all scores within the five day period had 
to fall within the range defined by the mean of the five days of 
error scores plus or minus one-half the average of those scores. At 
this point the subjects were injected with one of the following: 
isotonic saline, 0.5, 0.75, 1.0, or 2.0 mg/kg d-amphetamine. Each 
subject received each dose level. The order of administration of the 
various drug treatments was randomized for each subject. Fifteen 
minutes following the intraperitoneal injection the animals were run 
as usual. 
Results 
The data were analyzed in terms of s+, s--T, s--I, and ITI 
responding. Separate analyses of variance were performed on each of 
the response measures. This was done in order to present a more 
accurate representation of the effects of d-amphetamine on SDR res­
ponding. The statistical design used to te�t the results was that of 
a single factor experiment with repeated measures. 
Analysis of variance on the effects of the various drug doses 
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on s+ responding was significant (F=l3.04; df=4, 20; p<.Ol). Inspection 
of Table I and Figure 3 indicates that the dose levels of 0.5 and 0.75 
mg/kg have little effect on s+ responding. In contrast, administra­
tion of 1.0 mg/kg d-amphetamine resulted in a large decrease ins+ 
responding. Administration of 2.0 mg/kg d-amphetamine severely 
Dose 
Saline 
0.50 
0.75 
1.00 
2.00 
TABLE I 
Mean SDR Performance as Related to 
d-Amphetamine Dosage 
SDR Measures 
54 s--t s--t 
99.2 12.5 9.0 
99.5 5.2 3.7 
99.0 9.3 5.7 
72.8 4.2 2.7 
17.7 0.8 0.8 
ttl 
5.2 
7.7 
3.7 
5.8 
2.3 
disrupted responding on all SDR measures (Table I, Figure 3, Figure 
4). 
Although an analysis of variance did not reach significance 
fors--T responding (F=2.18, df=4,20), the analysis for s--1 res­
ponding was significant (F=3.20; df=4, 20; p<.05). Figure 4 shows the 
error scores for the individual animals. Five of the six animals 
show a decline in number of errors at the 0.5 mg/kg dose level. At 
0.75 mg/kg, two animals showed a further decrease in errors. At 1.0 
20 
mg/kg, error scores appeared to decrease; however, reinforced behavior 
was diminished as well, indicating disruption of performance. 
Inspection of Table I indicates that all dose levels of 
d-amphetamine tested had little effect on ITI responding. This is 
supported by an analysis of variance on ITI responding which failed 
to demonstrate significant differences between the dose levels (F=l.l3; 
df=4,20). 
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Figure 3.  Number of s+ responses under each drug condi ti on for 6 Ss-. 
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Discussion 
The dose levels tested appear to provide a suitable range of 
dose levels for the later studies of this series. The most effective 
dose tested for reducing errors was 0 . 5  mg/kg. The consistency ef 
responding between subjects noted at the 0 . 5  mg/kg level diminishes 
at the 0 . 75 mg/kg and 1 . 0 mg/kg levels. While some animals have 
decreased error rates at these levels, the remaining animals appear to 
have experienced some disruption. This effect is not as notable 
at 0.75 mg/kg as at 1 . 0 mg/kg, implying that 0.75 mg/kg is approaching 
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a disruptive level. Similarly, although 1 .0 mg/kg is not as disruptive 
as 2 . 0  mg/kg, it is disruptive for three of six subjects. Clearly, 
2.0 mg/kg results in severe disruption of all SDR responding. Because 
of the highly disruptive nature of this dose level, 2.0 mg/kg was 
eliminated as a dosage for further experimentation in studies reported 
here. 
CHAPTER III 
THE EFFECTS OF AMANTADINE HYDROCHLORIDE ON REPEATED 
ACQUIS ITION WITH SERIAL DISCRIMINATION 
REVERSALS 
Amantadine hydrochloride (1-adamantananine hydrochloride) has 
been reported (Vernier et al. , 1969 ; Stramberg and Svensson, 1971) 
to be a central nervous system stimulant in experi mental animals . 
However, it was recently reported by Menon, Clark, and Fleming (1973) 
that the hyperactivity caused by d-amphetamine was greatly reduced in 
amantadine HCl pretreated mice. For this reason, amantadine hydro­
chloride was selected as the drug to be administered in conjunction with 
d-amphetamine to determine what effect it might have on the central 
nervous system effects on d-amphetamine on SDR responding. 
Very little research on the behavioral effects of amantadine HCl 
has been reported. Those that have, like the Menon , Clark, and Fleming 
study, are mainly concerned with motor activity and gross behavioral 
signs of central nervous system stimulation. The majority of the 
studies, a few of which are reported here, are concerned with the mech­
anism of action of the drug. 
In a series of studies reported by Vernier et al. (1969) it was 
reported that at high dose levels central nervous system stimulation, 
anorexia, emesis, and some convulsions were noted. Included in the 
catch-all 11Signs of CNS stimulation .. were: ·increased spontaneous 
motor activity, antagonism of tetrabenazine-induced sedation, 
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piloerection, tremors, increased sensitivity to environmental stimuli, 
and convulsions. In the Vernier et al • . report, toxic effects for at 
least five dose levels were given for several species. The toxic signs 
produced by lethal or near-lethal doses of amantadine HCl in these 
species were similar. Signs of CNS stimulation, followed by tremors 
and clonic convulsions were common to three rodent species (mice, 
rats, and guinea pigs) by all routes of administration. Death was 
usually preceded by signs of respiratory distress and convulsions. 
The LD-50 for female rats was reported to be 223 mg/kg when administered 
intraperitoneally; and the peak effect of the drug was reported to 
occur two hours after injection. 
Vale, Espejil, and Dominguez (1971) reported a controlled 
trial of amantadine in depressive cases. Forty patients with two 
examiners• diagnoses of "chronic depressive syndrome" were used as 
subjects. The drugs the patients were taking were continued unchanged 
and each patient recieved at random one of three treatments: 
Group A ( 10 Ss) : 
Group B {10 Ss) : 
Group C (20 Ss) : 
100 mg daily for weeks 1 and 2 
200 mg daily for weeks 3 and 4 
200 mg daily for ·weeks 1 and 2 
1 00 mg daily for weeks 3 and 4 
were given an inactive preparation 
for four weeks, with the number of 
pills being increased or decreased 
as in Groups A and B. 
Thirty-four subjects completed the experim�nt. There were no signif-
icant differences between groups A and B; they were, therefore, 
combined for the rest of the evaluation. Restlessness and anxiety 
were apparent in 20 percent of the patients on a mean of 10 days. 
The difference between the combined AB group and Group C was 
significant (14/18 in AB showed improvement while only 6/16 in C).  
The conclusion reached was that although amantadine is less effective 
than some other agents in the treatment of depression, it does have 
some antidepressant properties. 
Cox and Williams (1972) investigated the cardiovascular actions 
of amantadine and attempted to confirm its interaction with dopamine. 
They concluded that amantadine is a weak pressor agent in the rat 
and rabbit but that is neither dopamine-like or tyramine-like in its 
action. 
Several other studies were concerned with the mechanisms of 
action of amantadine. Fletcher and Redfurn (1970) concluded from the 
Vernier et al. report of 1969 that high doses of amantadine might 
inhibit uptake of noradrenalin into peripheral nerve endings. It 
was reasonable then to suppose a similar action would take place on 
the uptake of dopamine and would help explain the antiparkinsonian 
effects of amantadine. Results of this experiment, however, make 
it a ppear unlikely that the central stimulation of amantadine would be 
due to the inhibition of uptake into central nerve endings. Herblin 
(1972) al so examined the effects of amantadine on the uptake of 
norepinephrine and dopamine by synaptosomes from the striatum and 
hypothalamus of normal and reserpine treated rats. He found that 
amantadine HCl inhibits the uptake of norepinephrine in both areas 
but is more potent against the hypothalamic system. Reserpine has 
little effect on either amount of uptake or the extent of inhibition. 
Like4the Fletcher and Redfurn study, the results here make it seem 
unlikely tha t inhibition of uptake is involved. 
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Several studies have examined the effects of amantadine HCl 
on locomotor activity in the rat. Fibigar, Fox, McGeer, and McGeer 
(1971) found significant increase in activity which is dose and time 
dependent. The doses used in the study were 20, 50, or 100 mg/kg 
amantadine in an aqueous solution. One-half hour after a subcutaneous 
injection of the drug, the animal was placed in a 35 em diameter cage. 
Movement was recorded for three hours. All doses produced significant 
increases in activity: 25 mg/kg increased activity early in the three 
hour period ; 50 mg/kg increased activity throughout the period , and 
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100 mg/kg increased activity during the last hour of the three hour 
period. Another study inve�tigating stimulation of motor activity by 
amantadine was carried out by Maj, Sominska, and Baran (1972). In this 
study, intraperitoneal injections ranging from 20 mg/kg to 80 mg/kg 
were used. It was found that amantadine moderately stimulates motor 
activity. Doses of 80 mg/kg doubled activity while higher doses 
depressed it. For the dose range investigated, amantadine abolished 
induced catalepsy. A third study, reported by Lassen (1973), compared 
amantadine with amphetamine as to its effect on motility. Drugs were 
administered subcutaneousl y and motil ity was measured for six hours 
following drug administration. Treatment with either of the two 
drugs increased motility significantly as compared to the sal ine 
control group. In the discussion of his findings, Lassen reports: 
The behavior effects of amantadine in rats may depend on a 
combination of mechanisms involving certain catecholamine 
systems . Amantadine may exert both a DA-receptor stimulating 
effect as well as a DA and NA release. The rotational 
behavior elicited by amantadine in rats with unilateral 
nigrostriatal lesions indicated that dopamine release pre­
dominates over dopamine acceptor stimulation in the striatum. 
The failure of amantadine to elicit stereotyped behavior 
suggests that it activates a special dopamine system or 
simultaneously activates a NA system with behavioral modu­
lating effect. 
The final study, also involving activity, is that of Menon, Clark, and 
Fleming (1973) which investigated the effects of amantadine pretreat­
ment on d-amphetamine induced hyperactivity in mice. Within 15 
minutes animals treated (i.p. injection) with either 2.0 or 5.0 mg/kg 
d-amphetamine showed hyperactivity. Animals receiving amantadine 
(150 mg/kg) alone were hyperactive immediately after injection but, 
unlike d-amphetamine, jerky movements occurred unaccompanied by 
exopthalamos and piloerection. The animals were sensitive to touch 
and some convulsions were noted. Pretreatment with amantadine com-
pletely blocked practically all the effects of amphetamine. 
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In order to ascertain whether the effects of d-amphetamine could 
be blocked by amantadine, it was important to determine a dosage of 
amantadine which did not cause a substantial effect in its own right, 
but one that merely blocked the effect of amphetamine usually ob-
served. 
The lower limit of LD-50 for amantadine in female rats was 
reported to be 167 mg/kg (Vernier et al., 1969) . However, as low a 
dose as 100 mg/kg reportedly caused a significant decrease in weight 
gain as well as resulting in increased mortality. Also, behavioral 
signs of CNS stimulation were evident at this dosage. In the studies 
reported by Vernier et al., the lowest dose used was 16 mg/kg which 
was virtually ineffective. 
Because of these reports, Experiment II was undertaken to 
i nvesti gate the effects of several dosages of amantadi ne i n  the range 
of 1 0  mg/kg to 1 00 mg/kg . I t  was hoped that thi s woul d provi de an  
upper and l ower l imi t for the effects of the drug for the purposes 
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of thi s  study. When the data from Experiment I I  i ndi cated the des i ra­
bi l i ty of us i ng a l ower dose  l evel , Experiment I I I  was performed to 
ascertai n the effects of three l ower dosage l evel s of amantadi ne hydro­
chl ori de on SDR performance . 
General Method 
Subjects 
Experiments I I  and I I I  each empl oyed 1 2  experimental ly na i ve, 
mal e  Wi star rats ( 250-350 g )  obta i ned from Hol tzman Co . ,  Madi son , 
Wi scons i n .  The an imal s were housed three per cage and were mai nta i ned 
on a 23 hour water depri vati on schedul e duri ng the experimenta l  
testi ng . Food was ava i l abl e ad l i b i tum throughout the course of the 
experiment .  
Apparatus 
The apparatus used i n  Experiment I was uti l i zed. 
Procedure 
The procedure was i denti ca l  to that used i n  Experiment I .  
Experiment I I .  The s i x  subjects were run on SDR unti l per­
formance stabi l i zed . The same cri terion for stabi l i ty as i n  Experi ­
ment I was used . After reachi ng a stabl e basel i ne ,  the subjects were 
i nj ected w i th one of the fol l owi ng : i sotoni c  sal i ne ,  1 0, 20, 40, or 
80 mg/ kg amantadi ne hydrochl ori de .  Each s ubject recei ved each dose 
level. The order of admini stration of treatments was randomized for 
each subject. Injections were intraperitoneal and were given 90 
minutes prior to the 200 tri al sess i on. 
Experiment III. Six naive subjects were run on SDR until 
performance stabilized. At this point each subject received one of 
the following : isotonic saline, 2. 5, 5. 0, or 7. 5 mg/kg amantadine 
hydrochloride. Each subject received each dose level, with order 
of administration randomized for each subject. Injections were intra­
peritoneal and were given 90 minutes prior to the session. 
Results 
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The data for Experi ments II and III were analyzed i n  terms of 
the four response meas ures. In each experiment an analysis of variance 
+ - -was performed on each of the four SDR meas ures :  S , S -T, S -1 , ITI. 
A s ingle-factor, repeated measures design was employed in the analysis. 
In Experiment II, the analyses of variance performed on s+ , s·-T, and 
s--1 were significant (S+ : F=l8. 15 , df=4, 20, p< . Ol; s·-T:  F=l9. 61, 
df=4, 20 ,  p<. Ol ;  S--1 : F=l7. 57, df=4, 20 ;  p< . Ol) . There was little 
effec t on ITI res pond i ng ( F=2 . 46 ,  df=4 , 20 ) . Inspecti on of Tabl e I I  
indicates that increasing dosage of amantadine, 10, 20, 40 , and 80 
mg/kg reduced responding on s+. The drug initially elevated errors 
as indicated by the means for both s--T and s--1.  ITI responding was 
little effected except at 80 mg/kg where the animals were generally 
debilitated and performed very little if at all. 
The results of Experiment III were analyzed in the same manner 
as those of Experiment II. No significant differences were found. 
Dose 
TABLE I I  
Mean SDR Performance as Rel ated to Amantadi ne 
Hydroch 1 ori de- -H.i gh Dosages 
SDR Measures 
5" s--t s--t 
sal i ne 95 . 3  27 . 5  1 6 . 5  
1 0 . 0  95 . 3  42 . 0  40 . 0  
20 . 0  87 . 5  69 . 2  42 . 3 
40 . 0  70 . 7  52 . 3  35 . 3  
80 . 0  1 5 . 5  1 9 . 8  1 3 . 5  
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ttl 
1 6 . 8  
1 2 . 5  
1 3 . 2  
1 7 . 0 
2 . 2 
Inspection of Tab l e  I I I  s upports thi s stati sti ca l  ev i dence. As dosage 
i ncreased from 2 . 5 to 7 . 5  mg/kg , s+ respondi ng decl i ned very l i ttl e. 
Li kewi se , S--T , S- - I , and ITI respondi ng showed l i ttl e ,  if any , change , 
D i scus s i on 
For the purpose of thi s  seri es of stud ies , the dosages tested 
i n  Experiment I I  were cl earl y too h igh. The highest dosage tested , 
80 mg/ kg , resu l ted not only  i n  severe di srupti on of performance , b ut 
al so i n  symptoms of CNS over-sti mul ati on. Several an i mal s were 
observed to have convul s i ons  at th i s  dose l evel. 
The effects of the other dosages tested i n  Experiment I I  were 
not as severe as the 80 mg/ kg dose l evel ; however , al l caused a decl i ne 
i n  perfermance. These resu l ts i ndi cated that a downward extens ion ef 
the dosage l evel s was needed. 
Experi ment I I I , testi ng 2 . 5 ,  5 . 0 ,  and 7 . 5  mg/ kg amantadi ne , 
previ ded the l evel of dosage needed. At the l owest dose , l i ttl e effect 
Dose 
TABLE III 
Mean SDR Performance as Related to Amantadine 
Hydrochlori qe�-Low Dosages 
SDR Measures 
s• s--t s--1 
saline 99. 5 16. 7 10. 5 
2. 5 99. 2 19. 5 13 . 3  
5. 0 98. 0  22. 0 15. 7 
7. 5 93. 5  19. 2 13. 0  
ITI 
13. 7  
11. 2 
15. 0 
11 . 8  
on anv SDR measure was observed. Effects after injections wfth 5. 0 
and 7. 5 mg/kg were also negli gi ble . From these results , al l dosages 
in Experiment II were eliminated for further use in this study. 
Because there was so little difference in the dosages tested in 
Experiment III , it was determined that all three, 2. 5, 5 . 0 , and 7. 5 
mg/kg, would be used in the final study in this series. 
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CHAPTER IV 
AN INVESTIGATION OF THE INTERACTION OF d-AMPHETAMI NE AND 
AMANTADINE HYDROCHLORIDE USING REPEATED ACQUISITIONS 
WITH SERIAL REVERSAL DISCRIMI NATIONS 
It it known that the central stimulatory effect of d-amphetamine 
is correlated with its ability to cause an increased release of brain 
dopami ne. Because of this , . the pharmacological effects of d­
amphetamine are effectively block�d ei ther by drugs which block the 
central dopamine receptors or by those which block the synthesis 
of dopamine. These amphetamine antagonists are central nervous sys­
tem depressants. The interesting aspect of the Menon , Clark , and 
Fleming (1973) study is that amantadine, a central nervous system 
sti mulant which has effects i n  common with those of d-amphetamine, 
effectively blocked the pharmacologi cal and biochemical effects of 
d-amphetami ne. 
Several reasons for this effect have been suggested , the most 
popular of which is competi ti ve antagoni sm. Drugs acting at the 
same si te are capable of blocki ng the effects of one another. A 
si milar site of acti on also means that the agoni st and antagonist 
wi ll have simi lar pharmacological effects. Many si mil ari ties between 
the acti ons of amantadi ne HCl and d-amphetami ne could be c i ted. As 
well as the central nervous system stimulant properti es such as 
enhanced motor activi ty ( Vernier et al. , 1969; StrHmberg and Svensson , 
1971) , bath cause uni laterally striatectomized rats to rotate toward 
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the operated s i de ( StrHmberg and Svensson , 1 971 ) ,  and cause i nhi bi ti on 
of uptake of catechol ami nes by central nerve termi nal s ( Cayl e and 
Snyder , 1 969 ; Scatton et al . ,  1 970 ) . The central effects of bath 
drugs are i nhi bi ted by a l pha-methyl tyrosi ne ( StrHmberg et a l . ,  1 970)  
and both drugs cause a decrease in  the accumul ati on of bra i n norepi ne­
phri ne after 1 -dgpa ( StrHmberg et al . ,  1 970 ) . From these s imi l ari ti es 
i t  i s  reasonabl e to s uggest that these drugs act at the same s i te ,  and 
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due to its res i stence to bi otransformati on i n  mi ce ( B l ei dner et a l . ,  1 965 )  
it  i s  further s uggested that amantadi ne stays at the s i te of  acti on 
a l ong time , thereby preventi ng amphetami ne from exerti ng i ts usual  
effects . 
Experiments I ,  I I ,  and I I I  determi ned the dose l evel s for 
d-amphetami ne and amantadi ne hydrochl ori de whi ch provi ded the appro­
priate effects for use i n  Experiment IV . I n  Experiment IV , combi na�  
t ions  of  the vari ous dose l evel s of each drug were admi n i stered . 
The purpose of the experiment was to determi ne whether amantadi ne hydro­
chl ori de coul d bl ock the effects of d-amphetami ne usua l l y  observed on 
SDR performance . 
General Method 
Subjects 
The s ubjects were 24 experimental ly  na i ve ,  ma l e  Wi star rats 
( 220-250 g) obta i ned from Hol tzman Co . ,  Madi son , Wi scons i n .  The 
animal s were housed three per cage and were ma i nta i ned on a 23 hour 
water depri vati on schedul e duri ng the experimental testi ng . Food was 
ava i l abl e ad l i b i tum throughout the course of the experiment .  
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Apparatus 
The apparatus descri bed i n  Experiment I was used i n  the present 
study . 
Procedure 
The di screte tri al operant SDR procedure descri bed i n  Experiment 
I was used i n  the present study . 
Experiment IV . The 24 animal s were randoml y di vi ded i nto four 
groups of s i x  an imal s .  After reachi ng a stabl e basel i ne ,  each animal 
recei ved , 90 mi nutes pri or to the sess i on , one of the fol l owi ng : 
i sotoni c  sal i ne ,  2 . 5 , 5 . 0 ,  or 7 . 5  mg/ kg amantadi ne hydrochl ori de . 
Fi fteen mi nutes pri or to the sess ion , the animal s were i njected wi th 
the dosage of d-amphetami ne ass i gned to i ts group : 0 . 5 ,  0 . 75 ,  or 1 . 0 
mg/ kg , or sal i ne .  The order of amantadi ne treatments wi thi n each 
group was determi ned as i n  previ ous experi ments , Al l i njecti ons were 
i ntraperi toneal . 
Resul ts and Di scuss i on 
The stati sti ca l  des i gn used to test the resu l ts was a two­
factor ana lys i s  of vari ance wi th repeated measures on one factor . 
A separate ana lys i s  of vari ance was performed on  each of the dependent 
+ - -measures : S , S -T ,  S - I , and ITI . 
The ana lyses for s+ respondi ng (Tabl e IV ) and ITI respondi ng 
(Tabl e V )  i ndi cated that there were no s i gn if i cant di fferences between 
the dose l evel s of amantadi ne .  S imi l arl y ,  these analyses s howed non­
s i gn i fi cant effects due  to the i nteracti on between amantadi ne and 
TABLE IV 
Summary Table for Analysis of Variance: 
s+ Responding 
Source df ss MS 
Between Subj ects 23 10 .070 . 12 
Amphetamine dose levels 3 1. 094 . 21 364. 70 
Error between 20 8 , 975. 92 448. 80 
Within Subj ects 72 11. 772. 50 
Amantadine dose levels 3 1 ' 134 . 54 378. 20 
Interaction 9 1 ' 700. 10 188. 90 
Error within 60 8 ,8 77 . 85 147. 96 
Total 95 
TABLE V 
Summary Table for Analysis of Variance: 
ITI Responding 
Source df ss MS 
Between Subjects 23 27 , 730. 33 
Amphetamine dose levels 3 2 , 759.41 919. 80 
Error between 20 24 ,970 . 90 1, 248. 55 
Within Subj ects 72 32, 001. 00 
Amantadine dose levels 3 1, 994. 41 664. 80 
Interaction 9 2 , 711. 18 301. 24 
Error within 60 27 , 301. 41 455. 02 
Total 95 
36 
F 
0. 81 
2. 56 
1. 28 
F 
0 . 74 
1. 46 
0 . 66 
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d-amphetamine. These results for drug combinations on s+ and ITI re­
sponding were not surprising. Because the animals are usually performing 
at close to optimal levels on s+ trial s it is difficult for results 
following drug administrations to reach significan ce unl ess a large 
decrement in s+ responding  takes place. ITI responding is often little 
affected by drug trials. This observation was upheld by the data 
obtained in Experiment IV which showed no significant differences in 
I TI respond ing resulting from various amantadi ne dosages , d-amphetami ne 
dosages, or from an interaction of the two drugs.  
The analyses of the s--T and  s--I data revealed results similar 
to those for s+ and ITI responding . For both measures, the effects 
due to aman tadine dose levels, or to the interaction between · 
d-ampheta mi ne and amantadi ne  dose levels, were non-significant ;  how­
ever, the effects due to the various d-amphetamine dose levels was 
si gni ficant ( see Table VI and Table VII) . Further analyses of the 
TABLE VI 
Summary Table for Analysis of Variance: 
s--T Responding 
Source df ss MS 
Between Subjects 23 1 1 , 840 . 24 
Amphetamine dose. levels 3 6 , 097 . 20 2 , 032 . 40 
Error between 20 5 , 743 . 04 287 . 1 5  
Wi thin Subjects 72 9 , 822 . 2 5 
Amantadine dose levels 3 81 4 . 78 21 7 . 59 
Interaction 9 1 , 1 1 5 . 34 1 23 . 93 
Error within 60 7 , 892 . 1 3  1 31 • 54 
Total 95 
*p< . Ol 
F 
7 . 08* 
1 . 65 
0 . 94 
TABLE VII 
Summary Table for Analysis of Variance: 
s--I Responding 
Source df ss MS 
Between Subjects 23 5, 378 .00 
Amphetamine dose levels 3 3 , 200. 33 1 , 066.78 
Error between 20 2, 177.67 108.88 
Within Subjects 72 2, 966.50 
Amantadine dose levels 3 �18.58 72.86 
Interaction 9 243.92 27. 10 
Error within 60 2, 505. 00 41.75 
Total 95 
*p<. 01 
F 
9.80* 
1 .  74 
0.65 
s--T and s--I data indicated there were no significant differences 
between the d-amphetamine groups following pretreatment with 5.0 mg/kg 
amantadine (see Table VIII and Table IX) .  However , pretreatment wi th 
saline, 2.5, or 7.5 mg/kg amantadine did resul t in significant differ­
ences between the d-amphetamine dose levels (see Tables X to XV) . 
Tukey-hsd multiple comparison tests were performed on each of these 
significant analyses . 
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The results of the multiple comparison tests were essentially 
the same for s--T and s--1 responding. Following pretreatment with 
either saline or 7.5 mg/kg amantadine there were significant differ­
ences between the control treatment (saline) and all dosages of 
d-amphetamine (p<.05) . However , there were no significant differences 
between the various d-amphetamine dose levels . Following pretreatment 
Source 
TABLE VIII 
ANOVA Summary Table : S--I Responses . Differences in 
d-Amphetamine Dosages with 5. 0 mg/kg 
Amantadine Pretreatment 
df ss MS F 
Amphetamine dose levels 
Error 
3 
20 
532. 83 
1, 785. 67 
177. 61 
89. 28 
1. 98 ns 
Source 
Total 23 2,318. 50 
TABLE IX 
ANOVA Summary Table : s--T Responses. Differences in 
d-Amphetamine Dosages with 5. 0 mg/kg 
Amantadine Pretreatment 
df ss MS F 
Amphetamine dose levels 
Error 
3 
20 
756. 12 
7, 149. 50 
252. 04 
357. 68 
0.70 ns 
Total 23 7, 905. 62 
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Source 
TABLE X 
ANOVA Summary Table : s·-T Responses. Differences in 
d-Amphetamine Dos.ages wi th. Sa 1 ine Pretreatment 
df SS MS F 
Amphetamine dose levels 
Error 
3 
20 
3 ,382. 73 1, 127 . 57 
3, 31 8 . 90 165, 94 
6 , 80* 
Total 23 6, 701. 63 
*p< . Ol 
Saurce 
TABLE X I  
ANOVA Summary Table : s·- I Responses. Differences in 
d-Amphetamine Dosages with Saline Pretreatmen t 
df ss MS F 
Amphetamine dose levels 
Error 
3 
20 
1, 260 . 46 
1, 472.50 
420.15 
73. 62 
5. 71* 
Total 23 2, 73 2.96 
*p<. 01 
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Saurce 
TABLE X I I  
ANOVA Summary Tabl e :  s·-T Responses . Di fferences i n  
d-Amphetami ne Dosages wi th 2 . 5  mg/ kg 
Amantadi ne Pretreatment 
df ss MS F 
Amphetami ne dose l evel s 
Error 
3 
20 
943 . 1 7  
1 , 1 67 . 33 
3 1 4 . 39 
58 . 37 
5 . 39* 
Tota l 23 2 , 1 1 0 . 30 
*p< . 01 
Saurce 
TABLE X I I I  
ANOVA Summary Tabl e :  s· - I  Responses . D i fferences i n  
d-Amphetami ne Dosages wi th 2 . 5  mg/kg 
Amantad i ne Pretreatment 
df ss MS F 
Amphetami ne dose l evel s 
Error 
3 
20 
586 . 46 
734 . 50 
1 95 . 49 
36 . 72 
5 . 32* 
Total 23 1 , 320 . 96 
*p< .  01 
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Source 
TABLE XIV 
ANOVA Summary Table : s--T Responses. Differences in 
d-Amphetamine Dosages with 7. 5 mg/kg 
Amantadine Pretreatment 
df ss MS F 
Amphetamine dose levels 
Error 
3 
20 
2, 130. 46 
1,999. 50 
710. 15 
99 . 98 
7 . 10* 
*p< . 01 
Saurce 
Total 23 4, 129. 96 
TABLE XV 
ANOVA Summa ry Table : s--1 Responses. Differences in 
d-Amphetamine Dosages with 7. 5 mg/kg 
Amantadine Pretreatment 
df ss MS F 
Amphetamine dose levels 
Error 
3 
20 
1, 064. 50 
690. 00 
354. 83 
34. 50 
10. 28* 
Total 23 1, 754.50 
*fJ<. 01 
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with 2. 5 mg/kg amantadine, the results of the control treatment (saline ) 
differed significantly ( p<. 05) from the results of treatment with 
either 0. 5 or 1. 0 mg/kg d-amphetamine. There were no significant 
differences between treatments of either 0. 75 d-amphetamine or saline, 
or between 0. 75 mg/kg d-amphetamine and the other d-amphetamine 
dosages. 
The fact that there is no significant interacti on between the 
d-amphetamine groups and the amantadine treatments indicated that the 
amantadine treatments did not block the effects that are usually noted 
following administration of d-amphetami ne i n  animals trained on SDR. 
In fact, · aside from the 5. 0 mg/kg amantadine pretreatment group, 
the results of the study merely further support the previous finding 
that d-amphetamine enhances learning af the discrimination i n  the 
procedure used here. Perhaps the most interesting finding is that of 
non-significant differences between the d-amphetamine treatments 
followi ng pretreatment with 5. 0 mg/kg amantadine. This might lead 
one to conclude that this pretreatment did, in fact, block the effects 
of the d-amphetamine treatments. A closer examination of the data 
{Table XV I )  i ndi cates there i s  some form of i nteracti on taki ng pl ace 
following thi s pretreatment, but whether it is a blockage of 
d-amphetami ne ' s  effect or merely a di sruption of the operant behavior 
i s  debatable. The results followi ng pretreatment with 5. 0 mg/kg 
amantadine revealed an increase in the number of errors after the 
0. 5 and 1. 0 mg/kg d-amphetamine treatments. Had this been the only 
� 
. 
observable difference i t  might be more readily concluded that pretreat­
ment with 5. 0 mg/kg amantadine blocked the central effects of 
TABLE XV I 
Table of Means for All SDR Measures 
for All Drug Combina tions 
d-Amphetamine 
Dose Levels 
Amantadine Dosa8es 
Saline 2.5 5.  7.5 
- - - - - - - mg/kg - - - - - -
S+R responding 
0 . 50 99 . 0  94 . 8  92 . 5  96 . 7  
0 . 75 99 . 2  97 . 5  92 . 0  94 . 0  
1 . 00 98 . 8  82 . 3  75 . 8  99 . 5  
Saline 98 . 1  97 . 3  98 . 5  97 . 5  
s-T reponding 
0 . 50 1 4 . 8 8 . 3  20 . 7  1 1  . 5 
0 . 75 1 0 . 7  1 2 . 7  1 2 . 7  5 . 3  
1 .  00 7 . 3  · 8 . 3  1 9 . 7  8 . 7 
Saline 37 . 7  23 . 7  28 . 5  29 . 7  
s- I responding 
0 . 50 6 . 8  6 . 8  1 0 . 5  7 . 0  
0 . 75 9 . 2  9 . 2  . 8 .  7 4 . 7  
1 . 00 6 . 8  6 . 5  1 2 . 8 4 . 7  
Saline 24 . 1  1 8 . 8  2 1 . 0  20 . 7  
IT I responding 
0 . 50 25 . 5  21 . 1 4 1 . 1  25 . 3  
0 . 75 1 6 . 5  1 5 . 0  1 6 . 3  1 1 . 8 
1 . 00 22 . 8  36 . 1  34 . 8  9 . 7  
Saline 25 . 7  21 . 1 33 . 3  28 . 9  
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d-amphetamine. However, s+ · responding was also affected. A decrease 
in s+ responding was noted for all d-amphetamine treatments following 
pretreatment with 5 . 0  mg/kg amantadine. This finding, together with 
the above reported effect on s--1 responding, l eads to the concl usion 
tha t this· i nteraction is more one of disruption of the operant response 
rather than blockage of the effects of d-amphetamine. 
CHAPTER V 
SUMMARY AND CONCLUSIONS 
The purpose of this series of studies was to determine the 
dose-effect relationships of d-amphetamine and amantadine hydrochloride 
and to determine what effects the interaction of these two compounds 
would have on acquisition . Experiment I indicated that 0 . 50 mg/kg 
d-amphetamine closely approximates the dosage which provi des for 
optimal performance on SDR . Dosages of l. O mg/kg and 2 . 0  mg/kg proved 
to be disruptive for performance on SDR . Experiments II and III 
investigating the dose response relationship of amantadine hydro­
chloride, indicated that dosages of 10 mg/kg and above resulted in 
detrimental effects on SDR performance, while dosages below 10 mg/kg 
seemed to have negligible effects on the task . In a general sense, 
the results from the final experiment indicate that amantadine hydro­
chloride did not block the effects of d-amphetamine on learni ng . 
To be more specific, in some instances, the interaction of the two 
drugs seems to be synergistic in nature rather than inhibitory . 
These resul ts do not impl y that previous findings which 
reported inhibition of the central effects of d-amphetamine were in 
error ; nor do they imply that the method empl oyed was faulty . It 
has previously been demonstrated that the repeated acquisition method, 
using serial reversal discriminations, is a sensitive and reliable 
method for determining drug effects on learning (Calhoun and Jones, 
1974). In addition, the · method has been shown to effectively 
46 
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demonstra te the effects of drugs on l earning in this series of studies. 
The resul ts of the control injections for amantadine across the 
various amphetamine dosages differ somewha t from the resul ts of Experi­
ment I. This effect is possibl y due to the extra handl ing and the 
second injection which were necessary in Experiment IV. Both handl ing 
and receiving injections are, at times, traumatic for an anima l and 
coul d resul t in a physiol ogica l change (biochemica l )  which might 
resul t in some interaction of the drug administered and the physical 
state of the anima l .  A second possibl e reason for this difference 
is that of group differences. General l y  speaking, when a wel l �control l ed 
behavioral basel ine such as the one empl oyed here is used for drug 
experimenta tion, additiona l subjects add l ittl e information. However, 
it is possibl e tha t this effect is due to a sampl ing probl em, and that 
a l arger number of subjects woul d provide a more concl usive dose­
response curve for d-amphetamine. 
A second point which woul d be interesting to investigate 
concerns the dose-effect curve for amantadine hydrochl oride. Most 
drugs can be administered at different l evel s to produce different 
effects , and it is not uncommon to find that a compl ete range of dosages 
resul ts in a dose-response curve with a mul tiphasic pa ttern. The 
dosages tested for amantadine revea l ed tha t higher dosages a ppear 
to disrupt performance. The second range of dose l evel s  tested indi­
cated l ittl e, if any, change. For the purpose of this series of 
studies, this was determined to be the l ower l imit of effect for 
amantadine hydrochl oride. However, it is possibl e  tha t l ower dose 
l evel s  wou l d  produce even a different effect. If these were tested 
and found to be stimul ant i n  nature i t  wou l d  be hel pful i n  expl a i n i ng 
some of the resu l ts i n  Experiment IV  which  i ndi cate that the i nter­
acti on af amphetami ne a nd amantadi ne was synerg i sti c  and stimu l atory .  
The resul ts ef Experiment I V  i ndi cated that there was l i ttl e 
i nteracti on between 2 . 5  mg/kg amantadi ne hydrochl ori de and the 
vari ous amphetami ne dosages . I t  appears that ,  fol l owi ng 5 . 0  mg/ kg 
amantadi ne pretreatment , there i s  a d i srupti on ef d i scrimi nati on 
whi ch i s  greatest wi th the 1 . 0 mg/kg d-amphetami ne combi nati on . 
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The resul ts fol l owi ng pretreatment wi th 7 . 5  mg/kg amantadi ne are 
i nteresti ng .  I t  appears that fol l owi ng th i s  pretreatment al l combi na­
ti ons wi th d-amphetami ne resul t in  an  enhancement of d i scrimi nation . 
Th i s  fi ndi ng i s  not i n  agreement wi th others reported herei n .  How­
ever , i t  i s  important to recal l that  prev i ous  stud ies reporti ng 
i nhi b i ti on of d-amphetami ne • s  effect fol l owi ng amantadi ne pretreatment 
were concerned wi th motor acti vi ty .  I t  i s  poss i bl e  that thi s  dose 
l evel of amantad i ne di d bl ock the hyperacti vi ty noted after d-amphetami ne 
admi n i strati on thereby i ncreas i ng attenti veness to the tas k .  
A second poss i bl e expl anati on for the resul ts fol l owi ng 7 . 5  
mg/kg amantadi ne pretreatment concerns  the hypothes i s  that st imu l ant 
drugs i ncrease moti vati onal l evel s ( Handl ey ,  1 97 1 ) .  Therefsre , the 
7 . 5 mg/ kg dose l evel of amantad i ne may be h igh  enough to bri ng the 
i ncreased moti vati onal l evel of the s ubjects fal l owi ng amphetami ne 
admi n i stration i nto a more optimal  l evel for di scrimi nati on tasks . 
A fi nal poss i b i l i ty as  an expl anati on for the resu l ts fol l owi ng 
pretreatment wi th 7 . 5  mg/ kg amantadi ne concerns the reports by vari ous 
authors (Herbl i n ,  1 972 ; Fl etcher and Redfurn , 1 970 ; Vern i er et a l . ,  
1969 ) that amantadine hydrochloride increases the effect of norepine­
phrine while at the same time inhibiting reuptake of norepinephrine 
inta nerve endings . The most plausible explanation for this evolves 
fram reports concerning the early use of amantadine hydrGchloride . 
Amantadine was fi rst used as a prophylactic treatment against Type 
A-2 influenza. Its use in preventing this viral infection was based 
an its ability to adsorb onto cells , thereby preventing viral absorp­
tion. Given the propensity of amantadine to coat cell membranes , it 
49 
is plausible that amantadine blocks the reuptake of norepinephrine at 
the presynaptic site leading to a prolonged or increased norepinephrine 
effect on postsynaptic receptors. Administration af amantadine merely 
serves to increase the amount of NE released from presynaptic stores 
and permits even greater norepinephrine effect on receptor sites. 
From this discussion , it should be clear that drug interactions 
are very complex in nature. However , the explanations suggested 
here for the results obtained in this series af studies do provide 
several possibilities as to interactions occurring . It is apparent 
that ,  due to the complex nature af a study such as this , further 
research should be pursued for the resul ts of th is study to be con­
clusive . The explanations offered here provide direction for future 
research concerning the interactions of d-amphetamine and amantadine 
hydrochloride. 
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